OnKure

OnKure is a biotech company in Boulder, United States, founded in 2011. It has raised $259.0M across 3 rounds, most recently a $150.0M Corporate Round in March 2026.

OnKure Therapeutics

Headquarters
Boulder, Colorado
Employees
11–50
Founded
2011
Total Funding
$259.0M
Last Round
$150.0M Corporate RoundMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancers and vascular anomalies underserved by available therapies. Using a structure-based drug design platform, OnKure builds a pipeline of small molecule drugs designed to achieve optimal efficacy and tolerability by selectively targeting specific mutations that drive cancer and other diseases. The company aims to become a leader in targeting oncogenic PI3Kα, with multiple programs designed for best-in-class targeting of this key oncogene.

Summary

It lists 11–50 employees. It has raised $259.0M in total across 3 rounds, most recently a $150.0M Corporate Round in Mar 2026. Investors include Surveyor Capital, BVF Partners and RA Capital Management.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundMar 2026
$150.0M

Sign up to see all 3 events

Funding: Series B through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OnKure on Indexed.vc
<a href="https://indexed.vc/companies/onkure"><img src="https://indexed.vc/api/badge/company/onkure" alt="OnKure on Indexed.vc" width="260" height="76" /></a>